[{"address1": "11711 North Meridian Street", "address2": "Suite 300", "city": "Carmel", "state": "IN", "zip": "46032", "country": "United States", "phone": "(317) 659-0200", "website": "https://mbxbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders. Its lead product candidate is MBX 2109, a parathyroid hormone peptide prodrug, which is in Phase 2 clinical trial for the treatment of chronic hypoparathyroidism. The company is also developing MBX 1416, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist that is in Phase 1 clinical trial a potential therapy for post-bariatric hypoglycemia, a chronic complication of bariatric surgery. In addition, it is developing MBX 4291, a lead obesity product candidate, which is in investigational new drug-enabling studies for the treatment of obesity and co-morbidities. The company was founded in 2018 and is based in Carmel, Indiana.", "fullTimeEmployees": 43, "companyOfficers": [{"maxAge": 1, "name": "Mr. Peter Kent Hawryluk MBA", "age": 55, "title": "CEO, President & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 571200, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Richard B. Bartram CPA", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2023, "totalPay": 578000, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.51, "open": 7.48, "dayLow": 7.09, "dayHigh": 7.85, "regularMarketPreviousClose": 7.51, "regularMarketOpen": 7.48, "regularMarketDayLow": 7.09, "regularMarketDayHigh": 7.85, "payoutRatio": 0.0, "forwardPE": -3.2703862, "volume": 217906, "regularMarketVolume": 217906, "averageVolume": 296195, "averageVolume10days": 451470, "averageDailyVolume10Day": 451470, "bid": 5.64, "ask": 9.31, "bidSize": 2, "askSize": 2, "marketCap": 254693920, "fiftyTwoWeekLow": 4.807, "fiftyTwoWeekHigh": 27.5, "fiftyDayAverage": 8.8064, "twoHundredDayAverage": 15.845369, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -7284293, "profitMargins": 0.0, "floatShares": 13610404, "sharesOutstanding": 33424400, "sharesShort": 4568242, "sharesShortPriorMonth": 4109163, "sharesShortPreviousMonthDate": 1740700800, "dateShortInterest": 1743379200, "sharesPercentSharesOut": 0.152, "heldPercentInsiders": 0.03243, "heldPercentInstitutions": 0.98616, "shortRatio": 21.97, "impliedSharesOutstanding": 33424400, "bookValue": 7.703, "priceToBook": 0.989225, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -61922000, "trailingEps": -5.82, "forwardEps": -2.33, "enterpriseToEbitda": 0.107, "52WeekChange": -0.67780125, "SandP52WeekChange": 0.05430484, "quoteType": "EQUITY", "currentPrice": 7.62, "targetHighPrice": 44.0, "targetLowPrice": 30.0, "targetMeanPrice": 37.4, "targetMedianPrice": 38.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 262148992, "totalCashPerShare": 7.843, "ebitda": -67950000, "totalDebt": 171000, "quickRatio": 23.783, "currentRatio": 24.187, "debtToEquity": 0.066, "returnOnAssets": -0.24168, "returnOnEquity": -0.36713, "freeCashflow": -33270250, "operatingCashflow": -54681000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MBX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1744921200, "regularMarketTime": 1744920001, "exchange": "NMS", "messageBoardId": "finmb_613097171", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 1.464709, "regularMarketPrice": 7.62, "shortName": "MBX Biosciences, Inc.", "longName": "MBX Biosciences, Inc.", "epsTrailingTwelveMonths": -5.82, "epsForward": -2.33, "epsCurrentYear": -2.73, "priceEpsCurrentYear": -2.7912087, "fiftyDayAverageChange": -1.1864004, "fiftyDayAverageChangePercent": -0.13472025, "twoHundredDayAverageChange": -8.225369, "twoHundredDayAverageChangePercent": -0.5191024, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.4 - Strong Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "postMarketChangePercent": 0.0, "postMarketPrice": 7.62, "postMarketChange": 0.0, "regularMarketChange": 0.10999966, "regularMarketDayRange": "7.09 - 7.85", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 296195, "fiftyTwoWeekLowChange": 2.8129997, "fiftyTwoWeekLowChangePercent": 0.5851882, "fiftyTwoWeekRange": "4.807 - 27.5", "fiftyTwoWeekHighChange": -19.880001, "fiftyTwoWeekHighChangePercent": -0.72290915, "fiftyTwoWeekChangePercent": -67.78013, "earningsTimestamp": 1742212803, "earningsTimestampStart": 1742212803, "earningsTimestampEnd": 1742212803, "isEarningsDateEstimate": false, "displayName": "MBX Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-04-19"}]